105 related articles for article (PubMed ID: 38742344)
1. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
Zhou J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
[TBL] [Abstract][Full Text] [Related]
2. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Differentiated High-Grade Thyroid Carcinoma Among Well-Differentiated Tumors: A Systematic Review and Meta-Analysis.
Poma AM; Macerola E; Ghossein RA; Tallini G; Basolo F
Thyroid; 2024 Mar; 34(3):314-323. PubMed ID: 38115626
[No Abstract] [Full Text] [Related]
4. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact.
Coca-Pelaz A; Rodrigo JP; Agaimy A; Williams MD; Saba NF; Nuyts S; Randolph GW; López F; Vander Poorten V; Kowalski LP; Civantos FJ; Zafereo ME; Mäkitie AA; Cohen O; Nixon IJ; Rinaldo A; Ferlito A
Virchows Arch; 2024 May; 484(5):733-742. PubMed ID: 38400843
[TBL] [Abstract][Full Text] [Related]
6. Advances in Thyroid Pathology: High Grade Follicular Cell-derived Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.
Xu B; Ghossein RA
Adv Anat Pathol; 2023 Jan; 30(1):3-10. PubMed ID: 36306188
[TBL] [Abstract][Full Text] [Related]
7. Cytologic features of aggressive variants of follicular-derived thyroid carcinoma.
Rossi ED; Faquin WC; Pantanowitz L
Cancer Cytopathol; 2019 Jul; 127(7):432-446. PubMed ID: 31150164
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid gland carcinoma].
Schmid KW
Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
[TBL] [Abstract][Full Text] [Related]
9. The 5
Basolo F; Macerola E; Poma AM; Torregrossa L
Endocrine; 2023 Jun; 80(3):470-476. PubMed ID: 36964880
[TBL] [Abstract][Full Text] [Related]
10. [Interpretation of the fourth edition of WHO pathological classification of the thyroid tumors in 2017].
Zhang Y; Wu QL; Yun JP
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):718-720. PubMed ID: 30293272
[TBL] [Abstract][Full Text] [Related]
11. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
[TBL] [Abstract][Full Text] [Related]
12. WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm.
Goswami P; Patel T; Dave R; Singh G; Singh A; Kalonia T
J Med Life; 2024 Jan; 17(1):15-23. PubMed ID: 38737660
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the 8
Ito Y; Miyauchi A; Hirokawa M; Yamamoto M; Oda H; Masuoka H; Sasai H; Fukushima M; Higashiyama T; Kihara M; Miya A
Endocr J; 2018 Jun; 65(6):621-627. PubMed ID: 29618671
[TBL] [Abstract][Full Text] [Related]
14. Thyroid neoplasms of follicular cell derivation: a simplified approach.
Asa SL; Mete O
Semin Diagn Pathol; 2013 Aug; 30(3):178-85. PubMed ID: 24144287
[TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated thyroid carcinoma.
Xu B; Ghossein R
Semin Diagn Pathol; 2020 Sep; 37(5):243-247. PubMed ID: 32360274
[TBL] [Abstract][Full Text] [Related]
16. Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
Kakudo K; Bai Y; Liu Z; Li Y; Ito Y; Ozaki T
Endocr J; 2012; 59(1):1-12. PubMed ID: 21908930
[TBL] [Abstract][Full Text] [Related]
17. Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation.
Zhang K; Wang X; Wei T; Li Z; Zhu J; Chen YW
Front Endocrinol (Lausanne); 2024; 15():1347362. PubMed ID: 38544687
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
Abe I; Lam AK
Histol Histopathol; 2021 Mar; 36(3):239-248. PubMed ID: 33170501
[TBL] [Abstract][Full Text] [Related]
19. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
[No Abstract] [Full Text] [Related]
20. Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience.
Sakamoto A
Endocr Pathol; 2004; 15(4):307-11. PubMed ID: 15681854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
